Review Article
Mesenchymal Stem Cell-Based Therapy for Allergic Rhinitis
Table 2
Summary of the applications of MSCs in AR model.
| Animals | Source of MSCs | Administration and dosage | Effect | Reference |
| BALB/c mice | BALB/c mice adipose tissue | Tail vein injection, , once a day for 3 days | Y | [35] | Albino rats | Albino rats adipose tissue | Intraperitoneal injection, , weekly for 3 weeks | Y | [36] | BALB/c mice | Human tonsil tissue | Intravenous injection, , once a day for 6 days | Y | [37] | Mice | Mice nasal mucosa | Tail vein injection, once a day for 3 days | Y | [38] | BALB/c mice | BALB/c mice bone marrow | Intravenous injection, , once a day for 2 weeks | Y | [39] | BALB/c mice | BALB/c mice bone marrow | Intraperitoneal injection, /, 1 dose | Y | [40] | Sprague-Dawley rats | Human umbilical cord | Intraperitoneal injection, /, 1 dose before/after AR rat model construction or weekly for 4 weeks after AR rat model construction | Y | [41] |
|
|
Abbreviations: Y: effect was shown.
|